Company at a Glance
Price
Overview
Ono Pharmaceutical Co., Ltd. is a Japanese-based pharmaceutical company that was founded in 1717. The company develops, manufactures, and sells prescription medicines and over-the-counter products for a wide range of medical conditions. Ono Pharmaceutical is headquartered in Osaka, Japan and has operations in Asia, Europe, and the United States.
The company focuses on research and development in the fields of oncology, immunology, and neurology. Its products include treatments for cancer, immune disorders, infectious diseases, and other areas of unmet medical need.
Ono Pharmaceutical is committed to ethical business practices and responsible corporate citizenship. The company has implemented various initiatives to reduce its environmental impact and contribute to the well-being of communities it operates in.
Ono Pharmaceutical has collaborations and partnerships with other pharmaceutical companies, research institutions, and universities to enhance its research capabilities and bring innovative medicines to patients.
Overall, Ono Pharmaceutical is dedicated to improving the health and quality of life of individuals worldwide through the development of innovative and effective medications.
What is special about the company?
📈 Want to read more about Ono Pharmaceutical?
Sign up for free
or
log in
⚡ Instantly access "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!
MS4gRm9jdX NlZCBvbiBS ZXNlYXJjaC BhbmQgRGV2 ZWxvcG1lbn Q6IE9ubyBQ aGFybWFjZX V0aWNhbCBo YXMgYSBzdH JvbmcgZm9j dXMgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCBpbnZlc3 RpbmcgYSBz aWduaWZpY2 FudCBwb3J0 aW9uIG9mIG l0cyByZXZl bnVlIGludG 8gdGhlIGRl dmVsb3BtZW 50IG9mIG5l dyBkcnVncy 4gVGhpcyBo YXMgYWxsb3 dlZCB0aGUg Y29tcGFueS B0byBpbnRy b2R1Y2UgaW 5ub3ZhdGl2 ZSBhbmQgZW ZmZWN0aXZl IHRyZWF0bW VudHMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMuPGJyPj IuIFN0cm9u ZyBQaXBlbG luZSBvZiBE cnVnczogT2 5vIFBoYXJt YWNldXRpY2 FsIGhhcyBh IHJvYnVzdC BwaXBlbGlu ZSBvZiBkcn Vncywgd2l0 aCBzZXZlcm FsIHBvdGVu dGlhbCBibG 9ja2J1c3Rl ciBkcnVncy BpbiBkZXZl bG9wbWVudC 4gVGhpcyBl bnN1cmVzIG EgY29udGlu dW91cyBzb3 VyY2Ugb2Yg cmV2ZW51ZS Bncm93dGgg aW4gdGhlIG Z1dHVyZS48 YnI+My4gR2 xvYmFsIFBy ZXNlbmNlOi BUaGUgY29t cGFueSBoYX MgYSBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggb3Blcm F0aW9ucyBp biBKYXBhbi wgdGhlIFVu aXRlZCBTdG F0ZXMsIGFu ZCBFdXJvcG UuIFRoaXMg YWxsb3dzIG l0IHRvIHRh cCBpbnRvIG RpZmZlcmVu dCBtYXJrZX RzIGFuZCBy ZWFjaCBhIH dpZGVyIHBh dGllbnQgcG 9wdWxhdGlv bi48YnI+NC 4gU3RyYXRl Z2ljIFBhcn RuZXJzaGlw czogT25vIG hhcyBmb3Jt ZWQgc3RyYX RlZ2ljIHBh cnRuZXJzaG lwcyB3aXRo IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyBhbmQgYm lvdGVjaCBz dGFydHVwcy B0byBkZXZl bG9wIG5ldy BkcnVncyBh bmQgdGVjaG 5vbG9naWVz LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdGhl IGNvbXBhbn kgYWNjZXNz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZXhw YW5kIGl0cy Bwcm9kdWN0 IHBvcnRmb2 xpby48YnI+ NS4gQ29tbW l0bWVudCB0 byBJbm5vdm F0aW9uOiBP bm8gUGhhcm 1hY2V1dGlj YWwgaGFzIG Egc3Ryb25n IGNvbW1pdG 1lbnQgdG8g aW5ub3ZhdG lvbiBhbmQg aXMgY29uc3 RhbnRseSBp bnZlc3Rpbm cgaW4gbmV3 IHRlY2hub2 xvZ2llcyBh bmQgYXBwcm 9hY2hlcyB0 byBib29zdC BkcnVnIGRl dmVsb3BtZW 50IGFuZCBp bXByb3ZlIH BhdGllbnQg b3V0Y29tZX MuPGJyPjYu IEZvY3VzIG 9uIFJhcmUg RGlzZWFzZX M6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBmb2 N1cyBvbiBy YXJlIGRpc2 Vhc2VzLCB3 aGVyZSB0aG VyZSBpcyBh IHNpZ25pZm ljYW50IHVu bWV0IG1lZG ljYWwgbmVl ZC4gVGhpcy Bjb21taXRt ZW50IGhhcy BsZWQgdG8g dGhlIHN1Y2 Nlc3NmdWwg ZGV2ZWxvcG 1lbnQgb2Yg c2V2ZXJhbC BkcnVncyBm b3IgcmFyZS BkaXNlYXNl cy48YnI+Ny 4gU29jaWFs IFJlc3Bvbn NpYmlsaXR5 OiBPbm8gUG hhcm1hY2V1 dGljYWwgaG FzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHNvY2lhbC ByZXNwb25z aWJpbGl0eS BhbmQgaXMg Y29tbWl0dG VkIHRvIHBy b3ZpZGluZy BhZmZvcmRh YmxlIGFuZC BhY2Nlc3Np YmxlIG1lZG ljaW5lcyB0 byBwYXRpZW 50cyBpbiBu ZWVkLjxicj 44LiBTdHJv bmcgRmluYW 5jaWFsIFBl cmZvcm1hbm NlOiBUaGUg Y29tcGFueS BoYXMgY29u c2lzdGVudG x5IGFjaGll dmVkIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggc3RlYWR5 IHJldmVudW UgYW5kIHBy b2ZpdCBncm 93dGguIFRo aXMgc3RhYm lsaXR5IGFu ZCBmaW5hbm NpYWwgc3Ry ZW5ndGggZ2 l2ZSB0aGVt IHRoZSByZX NvdXJjZXMg dG8gaW52ZX N0IGluIG5l dyBkcnVnIG RldmVsb3Bt ZW50Ljxicj 45LiBFbXBs b3llZS1Gcm llbmRseSBQ b2xpY2llcz ogT25vIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBKYXBhbi 4gSXQgaGFz IGEgcG9zaX RpdmUgd29y ayBjdWx0dX JlIGFuZCBl bXBsb3llZS 1mcmllbmRs eSBwb2xpY2 llcywgd2hp Y2ggaGF2ZS BoZWxwZWQg YXR0cmFjdC BhbmQgcmV0 YWluIHRvcC B0YWxlbnQu PGJyPjEwLi BDb21taXRt ZW50IHRvIF N1c3RhaW5h YmlsaXR5Oi BPbm8gaXMg Y29tbWl0dG VkIHRvIHN1 c3RhaW5hYm xlIGRldmVs b3BtZW50IG FuZCBoYXMg c2V0IHRhcm dldHMgZm9y IHJlZHVjaW 5nIGl0cyBl bnZpcm9ubW VudGFsIGlt cGFjdC4gVG hlIGNvbXBh bnkgYWxzby BzdXBwb3J0 cyB2YXJpb3 VzIHNvY2lh bCBpbml0aW F0aXZlcyBh bmQgaXMgd2 9ya2luZyB0 b3dhcmRzIG J1aWxkaW5n IGEgbW9yZS BzdXN0YWlu YWJsZSBmdX R1cmUu
What the company's business model?
📈 Want to read more about Ono Pharmaceutical?
Sign up for free
or
log in
👥 Free eBook for new users: "The Checklist Value Investor — A Smarter Way to Pick Stocks"
VGhlIE9uby BQaGFybWFj ZXV0aWNhbC BDb21wYW55 IGlzIGEgcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSB0 aGF0IGZvY3 VzZXMgb24g dGhlIHJlc2 VhcmNoLCBk ZXZlbG9wbW VudCwgcHJv ZHVjdGlvbi wgYW5kIHNh bGUgb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG lzIGJhc2Vk IG9uIHByb3 ZpZGluZyBp bm5vdmF0aX ZlIGFuZCBl ZmZlY3Rpdm UgbWVkaWNh bCBzb2x1dG lvbnMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMgYW5kIG 1lZGljYWwg Y29uZGl0aW 9ucy48YnI+ VGhleSBjb2 xsYWJvcmF0 ZSB3aXRoIH Jlc2VhcmNo IGluc3RpdH V0ZXMsIHVu aXZlcnNpdG llcywgYW5k IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyB0byBkZX ZlbG9wIG5l dyBkcnVncy BhbmQgdHJl YXRtZW50cy 4gT25vIFBo YXJtYWNldX RpY2FsIGFs c28gaGFzIG Egc3Ryb25n IGZvY3VzIG 9uIGludmVz dGluZyBpbi BjdXR0aW5n LWVkZ2UgdG VjaG5vbG9n aWVzIGFuZC Bjb250aW51 b3VzbHkgaW 1wcm92aW5n IHRoZWlyIG V4aXN0aW5n IHByb2R1Y3 RzLjxicj5U aGUgY29tcG FueSdzIG1h aW4gc291cm NlIG9mIHJl dmVudWUgY2 9tZXMgZnJv bSB0aGUgc2 FsZXMgb2Yg dGhlaXIgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IGJvdGggaW 4gSmFwYW4g YW5kIGludG VybmF0aW9u YWxseS4gVG hleSBoYXZl IGEgZGl2ZX JzZSBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgdGhhdC Bjb3ZlciB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzLCBzdWNo IGFzIG9uY2 9sb2d5LCBp bW11bm9sb2 d5LCBuZXVy b2xvZ2ljYW wgZGlzb3Jk ZXJzLCBhbm QgaW5mZWN0 aW91cyBkaX NlYXNlcy48 YnI+T25vIF BoYXJtYWNl dXRpY2FsIG Fsc28gdXNl cyBhIGxpY2 Vuc2luZyBi dXNpbmVzcy Btb2RlbCB0 byBleHBhbm QgdGhlaXIg cHJvZHVjdC Bwb3J0Zm9s aW8gYnkgcG FydG5lcmlu ZyB3aXRoIG 90aGVyIGNv bXBhbmllcy B0byBkZXZl bG9wIGFuZC Bjb21tZXJj aWFsaXplIH RoZWlyIHBy b2R1Y3RzIG luIGRpZmZl cmVudCBtYX JrZXRzLiBU aGV5IGFsc2 8gb2ZmZXIg Y29udHJhY3 QgbWFudWZh Y3R1cmluZy BzZXJ2aWNl cyB0byBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG dlbmVyYXRp bmcgYWRkaX Rpb25hbCBy ZXZlbnVlLj xicj5JbiBh ZGRpdGlvbi B0byB0aGVp ciBjb21tZX JjaWFsIGFj dGl2aXRpZX MsIE9ubyBQ aGFybWFjZX V0aWNhbCBh bHNvIGludm VzdHMgaW4g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBpbml0aW F0aXZlcyB0 byBjb250cm lidXRlIHRv IHRoZSB3ZW xsLWJlaW5n IG9mIHNvY2 lldHkuIFRo aXMgaW5jbH VkZXMgc3Vw cG9ydGluZy BoZWFsdGhj YXJlLXJlbG F0ZWQgcHJv amVjdHMgYW 5kIGluaXRp YXRpdmVzIG luIGRldmVs b3BpbmcgY2 91bnRyaWVz Ljxicj5Pdm VyYWxsLCB0 aGUgY29tcG FueSdzIGJ1 c2luZXNzIG 1vZGVsIGZv Y3VzZXMgb2 4gY29udGlu dW91cyBpbm 5vdmF0aW9u LCBzdHJhdG VnaWMgY29s bGFib3JhdG lvbnMsIGFu ZCBldGhpY2 FsIGJ1c2lu ZXNzIHByYW N0aWNlcyB0 byBwcm92aW RlIGhpZ2gt cXVhbGl0eS BhbmQgZWZm ZWN0aXZlIG 1lZGljYWwg c29sdXRpb2 5zIGZvciBw YXRpZW50cy B3b3JsZHdp ZGUu
Interesting facts about the company
📈 Want to read more about Ono Pharmaceutical?
Sign up for free
or
log in
🔓 Unlock our free guide: "The Checklist Value Investor — A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVE wySENGR0E3 dkdnVGtPa2 o0UGwud2Vi cCIgYWx0PS JPbm8gUGhh cm1hY2V1dG ljYWwiIHRp dGxlPSJPbm 8gUGhhcm1h Y2V1dGljYW wiICBjbGFz cz0iaW1nLW ZsdWlkIiBo ZWlnaHQ9OT Agd2lkdGg9 OTAgbG9hZG luZz0nbGF6 eScgc3R5bG U9J2JvcmRl ci1yYWRpdX M6IDZweDsn PgoKICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdmbG V4OiAxOyB0 ZXh0LWFsaW duOiBjZW50 ZXI7IG1hcm dpbi1sZWZ0 OiA1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPHAgc3 R5bGU9J2Zv bnQtc2l6ZT ogMjZweDsg Y29sb3I6IC MzMzM7IG1h cmdpbi1ib3 R0b206IDE1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIPCfk4 ggV2FudCB0 byByZWFkIG 1vcmUgYWJv dXQgT25vIF BoYXJtYWNl dXRpY2FsPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 8J+SoSBMZW FybiBzbWFy dGVyIHN0b2 NrIHBpY2tz IHdpdGggPG k+IlRoZSBD aGVja2xpc3 QgVmFsdWUg SW52ZXN0b3 Ig4oCUIEEg U21hcnRlci BXYXkgdG8g UGljayBTdG 9ja3MiPC9p PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8IS0t CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 1hcmdpbi10 b3A6IDEycH g7IGZvbnQt c2l6ZTogMT NweDsgY29s b3I6ICM0ND Q7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIFNpZ24g dXAgbm93IG FuZCBnZXQg b3VyIGZyZW UgZUJvb2sg CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 Yj5UaGUgQ2 hlY2tsaXN0 IFZhbHVlIE ludmVzdG9y IOKAlCBBIF NtYXJ0ZXIg V2F5IHRvIF BpY2sgU3Rv Y2tzPC9iPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTZweDsg Zm9udC1zaX plOiAxNHB4 OyBjb2xvcj ogIzQ0NDsg Zm9udC1mYW 1pbHk6IC1h cHBsZS1zeX N0ZW0sIEJs aW5rTWFjU3 lzdGVtRm9u dCwgU2Vnb2 UgVUksIFJv Ym90bywgSG VsdmV0aWNh IE5ldWUsIH NhbnMtc2Vy aWY7IGxpbm UtaGVpZ2h0 OiAxLjY7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIE hhdmUgeW91 IGhlYXJkIG Fib3V0IG91 ciBzaG9ydC A8c3Ryb25n IHN0eWxlPS dmb250LXdl aWdodDogNj AwOyc+RGFp bHkgVmlkZW 8gTmV3c2xl dHRlcjwvc3 Ryb25nPj8K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 h0dHBzOi8v d3d3Lmluc2 lnaHRmdWx2 YWx1ZS5jb2 0vbmV3c2xl dHRlci5waH AnIHRhcmdl dD0nX2JsYW 5rJyBzdHls ZT0nY29sb3 I6ICMwMDdC RkY7IHRleH QtZGVjb3Jh dGlvbjogbm 9uZTsgZm9u dC13ZWlnaH Q6IDUwMDsg bWFyZ2luLW xlZnQ6IDZw eDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIE ZpbmQgb3V0 IG1vcmUKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAK ICAgICAgIC AKICAgICAg ICA8c3Bhbi BjbGFzcz0n Ymx1cnJlZC 10ZXh0Jz4K ICAgICAgIC AgICAgYldG clpYTWdkRy BGaWJHVjBj enhpIGNqNH hMaUJHYjMg VnVaR1ZrSU dsdSBJREUz TVRjNklGIF JvWlNCUGJt OGcgVUdoaG NtMWhZMiBW MWRHbGpZV3 dnIFkyOXRj R0Z1ZVMgQj NZWE1nWm05 MSBibVJsWk NCcGJpIEF4 TnpFM0lHRn ogSUdFZ2RI SmhaRyBsMG FXOXVZV3dn IGFHVnlZbU ZzSUcgMWxa R2xqYVc1bC BJSE4wYjNK bElHIGx1SU U5ellXdGgg TENCS1lYQm hiaSA0Z1NY UWdkMkZ6IE lHTmhiR3hs WkMgQlBibT hnUjJWdSBl bUZsYlc5dU lGIE5vYjNS bGJpNDggWW 5JK01pNGdS VyA1MFpYSm xaQ0IwIGFH VWdjR2hoY2 0gMWhZMlYx ZEdsaiBZV3 dnYVc1a2RY IE4wY25rZ2 FXNGcgTVRn NU9Ub2dTVy A0Z01UZzVP U3dnIGRHaG xJR052Ylgg QmhibmtnYz NSaCBjblJs WkNCcGJYIE J2Y25ScGJt Y2cgY0doaG NtMWhZMiBW MWRHbGpZV3 dnIGNtRjNJ RzFoZEcgVn lhV0ZzY3lC bSBjbTl0SU dGaWNtIDlo WkNCaGJtUW cgWlc1MFpY SmxaQyBCMG FHVWdjR2ho IGNtMWhZMl YxZEcgbGpZ V3dnYVc1ay BkWE4wY25r dVBHIEp5UG pNdUlFWnAg Y25OMElFcG hjRyBGdVpY TmxJR052IG JYQmhibmtn ZEcgOGdiV0 Z1ZFdaaCBZ M1IxY21VZ2 NHIFZ1YVdO cGJHeHAgYm pvZ1NXNGdN VCBrME5pd2 dUMjV2IElG Qm9ZWEp0WV cgTmxkWFJw WTJGcyBJR0 psWTJGdFpT IEIwYUdVZ1 ptbHkgYzNR Z1NtRndZVy A1bGMyVWdZ Mjl0IGNHRn VlU0IwYnkg QnRZVzUxWm 1GaiBkSFZ5 WlNCd1pXID VwWTJsc2JH bHUgTGp4aW NqNDBMaSBC RVpYWmxiRz l3IFpXUWdT bUZ3WVcgN2 lnSmx6SUda cCBjbk4wSU hSeVlXIDV4 ZFdsc2FYcG wgY2pvZ1NX NGdNVCBrMU 5Td2dkR2hs IElHTnZiWE JoYm4ga2da R1YyWld4di BjR1ZrSUVw aGNHIEZ1NG 9DWmN5Qm0g YVhKemRDQj BjbSBGdWNY VnBiR2w2IF pYSWdZMkZz YkcgVmtJRV ZzWlc1cCBk VzBnUld4cG VHIGx5TGp4 aWNqNDEgTG lCTVlYVnVZ MiBnZ2IyWW dabWx5IGMz UWdaSEoxWn kgQm1iM0ln YUhsdyBaWE owWlc1emFX IDl1T2lCSm JpQXggT1RZ M0xDQlBibS A4Z1VHaGhj bTFoIFkyVj FkR2xqWVcg d2diR0YxYm 1ObyBaV1Fn ZEdobElHIF pwY25OMElH RnUgZEdsb2 VYQmxjbiBS bGJuTnBkbV VnIFpISjFa eUJwYmkgQk tZWEJoYmlC aiBZV3hzWl dRZ1EyIEZ3 YjNSbGJpND ggWW5JK05p NGdTVyA1MG NtOWtkV04w IGFXOXVJRz ltSUggUm9a U0JtYVhKei BkQ0JLWVhC aGJtIFZ6Wl MxdFlXUmwg SUdGdWRHbG pZVyA1alpY SWdaSEoxIF p6b2dTVzRn TVQgazNOQ3 dnZEdobCBJ R052YlhCaG JuIGtnYVc1 MGNtOWsgZF dObFpDQjBh RyBVZ1ptbH ljM1FnIFNt RndZVzVsYz IgVXRiV0Zr WlNCaCBibl JwWTJGdVky IFZ5SUdSeW RXY2cgWTJG c2JHVmtJRS BKdmMyTm9J RkJvIFlYSn RZU3dnZDIg aHBZMmdnYV hNZyBjM1Jw Ykd3Z2QyIG xrWld4NUlI VnogWldRZ2 RHOWtZWCBr dVBHSnlQam N1IElFTnZi R3hoWW0gOX lZWFJwYjI0 ZyBkMmwwYU NCTWFXIHhz ZVRvZ1NXNG cgTVRrNE1p d2dUMiA1dk lGQm9ZWEp0 IFlXTmxkWF JwWTIgRnNJ R1Z1ZEdWeS BaV1FnYVc1 MGJ5IEJoSU dOdmJHeGgg WW05eVlYUn BiMiA0Z2Qy bDBhQ0JGIG JHa2dUR2xz Ykgga2dZVz VrSUVOdiBi WEJoYm5rZ2 RHIDhnWkdW MlpXeHYgY0 NCaGJtUWdi VyBGeWEyVj BJSEJvIFlY SnRZV05sZF ggUnBZMkZz SUhCeSBiMl IxWTNSeklH IGx1SUVwaG NHRnUgTGp4 aWNqNDRMaS BCUVlYSjBi bVZ5IGMyaH BjQ0IzYVgg Um9JRUp5YV hOMCBiMnd0 VFhsbGNuIE 1nVTNGMWFX SmkgT2lCSm JpQXlNRCBB MkxDQlBibT hnIFVHaGhj bTFoWTIgVj FkR2xqWVd3 ZyBjMmxuYm 1Wa0lHIEZ1 SUdGbmNtVm wgYldWdWRD QjNhWCBSb0 lFSnlhWE4w IGIyd3RUWG xsY24gTWdV M0YxYVdKaS BJR1p2Y2lC MGFHIFVnWT I4dFpHVjIg Wld4dmNHMW xibiBRZ1lX NWtJR052IE xXTnZiVzFs Y20gTnBZV3 hwZW1GMCBh Vzl1SUc5bU lHIFJ5ZFdk eklHWnYgY2 lCallXNWpa WCBJc0lHTm xiblJ5IFlX d2dibVZ5ZG 0gOTFjeUJ6 ZVhOMCBaVz BnWkdsemIz IEprWlhKek xDQmggYm1R Z1lYVjBiMi BsdGJYVnVa U0JrIGFYTm xZWE5sY3kg NDhZbkkrT1 M0ZyBSMnh2 WW1Gc0lHIF Y0Y0dGdWMy bHYgYmpvZ1 QyNXZJRiBC b1lYSnRZV0 5sIGRYUnBZ MkZzSUcgaG hjeUJsZUhC aCBibVJsWk NCcGRIIE1n WW5WemFXNW wgYzNNZ2RH OGdiMyBabG NpQTROQ0Jq IGIzVnVkSE pwWlggTWdZ VzVrSUhKbC BaMmx2Ym5N Z1lYIEp2ZF c1a0lIUm8g WlNCM2IzSn NaQyB3Z2Qy bDBhQ0JoIE lHWnZZM1Z6 SUcgOXVJRU Z6YVdFcyBJ RTV2Y25Sb0 lFIEZ0WlhK cFkyRXMgSU dGdVpDQkZk WCBKdmNHVX VQR0p5IFBq RXdMaUJUZF ggTjBZV2x1 WVdKcyBaU0 JrWlhabGJH IDl3YldWdW REb2cgVkdo bElHTnZiWC BCaGJua2dh WE1nIFkyOX RiV2wwZEcg VmtJSFJ2SU hOMSBjM1Jo YVc1aFltIH hsSUdSbGRt VnMgYjNCdF pXNTBJRyBG dVpDQm9ZWE 1nIGMyVjBJ R2R2WVcgeH pJSFJ2SUhK bCBaSFZqWl NCcGRIIE1n Wlc1MmFYSn YgYm0xbGJu UmhiQyBCcG JYQmhZM1Fz IElIQnliMj F2ZEcgVWda R2wyWlhKei BhWFI1SUdG dVpDIEJwYm 1Oc2RYTnAg YjI0c0lHRn VaQyBCamIy NTBjbWxpIG RYUmxJSFJ2 SUggTnZZMm xsZEhrZyBk R2h5YjNWbm FDIEIyWVhK cGIzVnogSU dsdWFYUnBZ WCBScGRtVn pMZz09CiAg ICAgICAgPC 9zcGFuPgog ICAgICAgIA ogICAgICAg IA==
See Company Q&A
📊 Get full analytics about Ono Pharmaceutical
Sign up for free
or
log in
⚡ Instantly access "The Checklist Value Investor — A Smarter Way to Pick Stocks" — free!
